This showed a trend towards a higher proportion of CD8 naive cells in both scRNA-seq and flow cytometry data ( P = 0.051 and P = 0.065), suggesting microenvironmental differences between the two NPM1 classes affecting the T cell composition already at diagnosis.
Visual analysis Per-patient analysis showed a trend for a difference between Phases 1 and 2–3 in PET metabolism, which was more prominent in Phases 2–3 ( p = 0.051).
There was no significant difference in ADG at other timepoints ( P > 0.05); however, the LAS diet showed a trend to significance (adjusted P = 0.051) when compared to ZnO at week 4 ( Table 2 ).
On the other hand, when AD converters were analyzed in comparison with MCI/non‐AD subjects, a former or current smoking habit showed a trend to be a relatively protective factor for the progression to AD ( p = 0.051), even considering only a small cohort of individuals.
Notably, patients with long ALK variant/high B cells showed a trend toward longer PFS compared to other subgroups as shown in Figure 7E (P=0.051).
The MD group showed a trend toward fat mass gain ( p = 0.051), while the VLED/semaglutide group maintained stable fat mass ( p = 0.09).
The interaction of time × basepower showed a trend ( F 3,75 = 2.703, p = 0.051, η 2 = 0.098), while the factor group ( F 1, 25 = 0.931, p = 0.344, η 2 = 0.036) and the interaction time × mismatch did not reach significance ( F 3,75 = 1.478, p = 0.227, η 2 = 0.056).
In addition, baseline eGFR values showed a trend toward statistical significance (HR = 0.99, 95% CI: 0.97–1.00, p = 0.051).
Firstly, expression levels of Dnmt3a showed a trend toward an increase in GBH- and Gly-exposed groups in relation to control group ( Figure 5B ; p = 0.0510), while there was no difference when comparing the exposed groups.
In terms of age-related differences, in the YA subgroup, pFear was positively correlated with left S1 activation (r = 0.56, p = 0.011, coefficient of determination = 0.31) and the association between pFear and right S1 showed a trend of significance (r = 0.44, p = 0.051, coefficient of determination = 0.19).
When analyses were adjusted by line of treatment and recruitment country, two more variables — age under 12 years old and having an inflammatory phenotype — showed a trend towards improved response ( p = 0.051 and p = 0.085, respectively) (Table 6 ).
Plasma Appetite-Related Gut Peptides The LED pdr intervention showed a trend towards a decrease plasma GLP-1 (Week, p = 0.051) ( Table 4 ), without a significant difference between dietary groups (Protein×Week, p = 0.176; CHO×Week, p = 0.675; Protein×CHO×Week, p = 0.600) ( Supplementary Table S1 ).
NHHR exhibited significant negative correlations with hematoma volume ( r = −0.181, P = 0.010 ), while RC showed a trend toward a negative correlation (r = −0.138, P = 0.051 ).
A post hoc statistical test identified a significant increase in the rate of missteps in the stroke group (pre-test, 11.0 ± 2.1%; post-test, 13.5 ± 1.3%, p = 0.040; mean ± SD); the sham treatment group showed a trend of decreasing missteps (pre-test, 10.4 ± 2.0%; post-test, 8.1 ± 1.7%, p = 0.051; mean ± SD), whereas the stroke group had a higher rate of missteps compared to the sham treatment group at the post-test (p < 0.001) (Fig. 2 B, Supplementary Table S1 online).
Nevertheless, patients with high‐risk cytogenetics showed a trend toward lower 3‐year PFS than those without (77.8% vs. 89.4%, p = 0.051), and ultra‐high‐risk cytogenetics (≥2 high‐risk cytogenetics) had an even worse prognosis, with 61.2% 3‐year PFS.
Under control conditions (1000 s stimulation pause), waveforms in CA3a showed a trend towards increased diversity over time (median distances late/early recording period 1.08, p = 0.051, n = 11 data sets from 6 slices), which reached significance in CA3b (median 1.14, p = 0.016, n = 17 data sets from 9 slices).
Regarding gender, the distribution showed a trend ( χ 2 (5) = 11.02, p = .051, Cramer's V = .21).
The predicted therapeutic benefits of EVT also showed a trend towards increasing as NIHSS scores increased ( p = 0.051 for the linear trend test of ORs).
Multivariate analysis showed that PIK3R1 expression status was an independent predictor of MFS in the total population (p = 0.0013), whereas PIK3CA mutation status only showed a trend in the ERBB2+ population (p = 0.051).
Furthermore, the adjusted multiple regression models demonstrated that the MMSE score showed a trend toward an independent association with anterior DMN connectivity (p = 0.051).
Among 48 patients receiving 3L therapy, regorafenib showed a trend toward improved OS over sorafenib (HR, 0.33; 95% CI, 0.11 to 1.02; p=0.051), supported by restricted mean survival time analysis (p=0.028).
Moreover, the proportion of detected spines in MEC with filopodial morphology was negatively correlated with SD interventions required ( Figure 3 , bottom; Pearson’s r = −0.94, p < .05), while the proportion with stubby morphology showed a trend for positive correlation with SD interventions (Pearson’s r = 0.88, p = .051).
This phenomenon showed a trend to become significant with time (F (6,282) = 2.131, p = 0.051).
Both groups showed significant QoL improvements (DLQI scores) after 1 month ( p < 0.05), and agent A showed a trend toward greater improvement after adjusting for baseline DLQI (adjusted p = 0.051).
The analyses of number of reinforcers collected showed a trend for a main effect of exposure, F(3,25) = 3.0; p = 0.051 .